CFTR and ENaC functions in cystic fibrosis

被引:0
|
作者
Palma, Alejandra G. [1 ]
Kotsias, Basilio A. [1 ]
Marino, Gabriela I. [1 ]
机构
[1] Univ Buenos Aires, IDIM CONICET, Inst Invest Med Alfredo Lanari, Lab Cana Ion, Buenos Aires, DF, Argentina
关键词
cystic fibrosis; CFTR; ENaC; ionic movements; cytoskeleton; TRANSMEMBRANE CONDUCTANCE REGULATOR; GAP-JUNCTION CHANNELS; MUTATIONS; GENE; EXPRESSION; DELTA-F508; TRANSPORT; AMILORIDE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cystic fibrosis is caused by dysfunction or lack of the cystic fibrosis transmembrane conductance regulator (CFTR), a chloride channel that has a key role in maintaining ion and water honnoeostasis in different tissues. CFTR is a cyclic AMP-activated Cl- channel found in the apical and basal plasma membrane of airway, intestinal, and exocrine epithelial cells. One of CFTR's primary roles in the lungs is to maintain homoeostasis of the airway surface liquid layer through its function as a chloride channel and its regulation of the epithelial sodium channel ENaC. More than 1900 CFTR mutations have been identified in the cftr gene. The disease is characterized by viscous secretions of the exocrine glands in multiple organs and elevated levels of sweat sodium chloride. In cystic fibrosis, salt and fluid absorption is prevented by the loss of CFTR and ENaC is not appropriately regulated, resulting in increased fluid and sodium resorption from the airways and formation of a contracted viscous surface liquid layer. In the sweat glands both Na+ and Cl- ions are retained in the lumen, causing significant loss of electrolytes during sweating. Thus, elevated sweat NaCl concentration is the basis of the classic pilocarpine-induced sweat test as a diagnostic feature of the disease. Here we discuss the ion movement of Cl- and Na+ ions in two tissues, sweat glands and in the air surface as well as the role of ENaC in the pathogenesis of cystic fibrosis.
引用
收藏
页码:133 / 139
页数:7
相关论文
共 50 条
  • [31] Treatment of Cystic Fibrosis with CFTR Modulators
    Tuemmler, B.
    PNEUMOLOGIE, 2016, 70 (05): : 301 - 313
  • [32] CFTR MISLOCALIZATION IN CYSTIC-FIBROSIS
    RIORDAN, JR
    CHANG, XB
    KARTNER, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 8 - 8
  • [33] PULMONOLOGY CFTR modulators for cystic fibrosis
    Bertoncini, Erica
    Colomb-Lippa, Dawn
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2013, 26 (02): : 59 - 60
  • [34] Immunofluorescent localization of cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC) in human sweat ducts
    Brown, Mary Beth
    Vincent, Karla K.
    Millard-Stafford, Mindy
    McCarty, Nael A.
    FASEB JOURNAL, 2009, 23
  • [35] Correction of defective CFTR/ENaC function and tightness of cystic fibrosis airway epithelium by amniotic mesenchymal stromal (stem) cells
    Carbone, Annalucia
    Castellani, Stefano
    Favia, Maria
    Diana, Anna
    Paracchini, Valentina
    Di Gioia, Sante
    Seia, Manuela
    Casavola, Valeria
    Colombo, Carla
    Conese, Massimo
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2014, 18 (08) : 1631 - 1643
  • [36] Proteases, cystic fibrosis and the epithelial sodium channel (ENaC)
    P. H. Thibodeau
    M. B. Butterworth
    Cell and Tissue Research, 2013, 351 : 309 - 323
  • [37] Proteases, cystic fibrosis and the epithelial sodium channel (ENaC)
    Thibodeau, P. H.
    Butterworth, M. B.
    CELL AND TISSUE RESEARCH, 2013, 351 (02) : 309 - 323
  • [38] Knockdown of ENaCα as a Treatment for Cystic Fibrosis Lung Disease
    Harding-Smith, Rebekka E.
    Gill, Deborah R.
    Hyde, Stephen C.
    MOLECULAR THERAPY, 2011, 19 (07) : 1371 - 1371
  • [39] A new phase of CFTR treatment for cystic fibrosis?
    Bell, Scott C.
    LANCET RESPIRATORY MEDICINE, 2015, 3 (09): : 662 - 663
  • [40] Discovery of CFTR modulators for the treatment of cystic fibrosis
    Hadida-Ruah, Sara
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251